MSX2 and cancer: Despite the lack of modulation of PRAME by MSX2, it will be of enormous interest to further explore how PRAME controls human mesenchymal development and whether PRAME promotes carcinogenesis by giving the cells mesenchymal characteristics during cancer progression.